99-108. Proposed Data Collection; Comment Request; Physician Survey on Cancer Susceptibility Testing  

  • [Federal Register Volume 64, Number 2 (Tuesday, January 5, 1999)]
    [Notices]
    [Pages 519-520]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-108]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    Proposed Data Collection; Comment Request; Physician Survey on 
    Cancer Susceptibility Testing
    
    SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of 
    the Paperwork Reduction Act of 1995, for opportunity for public comment 
    on proposed data collection projects, the National Institutes of Health 
    (NIH), the National Cancer Institute (NCI) will publish periodic 
    summaries of proposed projects to be submitted to the Office of 
    Management and Budget (OMB) for review and approval.
    
    Proposed Collection
    
        Title: Physicians Survey on Inherited Cancer Susceptibility 
    Testing. Type of Information Collection Request: New. Need and Use of 
    Information Collection: The Physicians Survey on Inherited Cancer 
    Susceptibility Testing will be used by the National Cancer Institute to 
    establish baseline information on the prevalence of genetic testing for 
    cancer susceptibility among primary care physicians in the United 
    States. The survey will assess whether there are statistically 
    significant differences in (1) self-reported knowledge, current use of, 
    and future intentions to use genetic testing for cancer susceptibility, 
    and (2) perceptions of barriers to testing, among primary care 
    physicians by their type and location of practice, and recency of 
    training. Primary care physicians (internists, pediatricians, family 
    and general practitioners) will also be compared with specialty groups 
    (gastroenterologists, surgeons, urologists and oncologists) with 
    respect to their
    
    [[Page 520]]
    
    use, attitudes toward, and knowledge of, genetic testing for cancer 
    susceptibility. A questionnaire will be administered by mail, 
    telephone, facsimile and Internet, using a nationally representative 
    sample of physicians. The study physicians will select their preferred 
    response mode. Frequency of Response: One-time study. Affected Public: 
    Medical community. Type of Respondents: Primary care and specialty 
    physicians with active licenses to practice medicine in the U.S. The 
    annualized cost to respondents is estimated at $33,750. Burden 
    estimates are presented here:
    
    ----------------------------------------------------------------------------------------------------------------
                                                                        Estimated #   Average burden     Estimated
                      Questionnaire                     Estimated #     responses/       hours per     total annual
                                                        respondents     respondent       response      burden hours
    ----------------------------------------------------------------------------------------------------------------
    Primary care physicians.........................           1,096               1           0.250             274
    Specialty physicians............................             254               1           0.250              64
                                                     ---------------------------------------------------------------
        Total.......................................  ..............  ..............  ..............             338
    ----------------------------------------------------------------------------------------------------------------
    
    REQUEST FOR COMMENTS: Written comments and/or suggestions from the 
    public and affected agencies are invited on one or more of the 
    following points: (1) Whether the proposed collection of information is 
    necessary for the proper performance of the function of the agency, 
    including whether the information will have practical utility; (2) the 
    accuracy of the agency's estimate of the burden of the proposed 
    collection of information, including the validity of the methodology 
    and assumptions used; (3) ways to enhance the quality, utility and 
    clarity of the information to be collected; and (4) ways to minimize 
    the burden of the collection of information on those who are to 
    respond, including the use of appropriate automated, electronic, 
    mechanical, or other technological collection techniques or other forms 
    of information technology.
    
    FOR FURTHER INFORMATION CONTACT:
    To request more information on the proposed project or to obtain a copy 
    of the data collection plans and instruments, contact Louise Wideroff 
    or Andrew Freedman, Epidemiologists, National Cancer Institute, EPN 
    313, Executive Boulevard MSC 7334, Bethesda, Maryland 20892-7344, 
    Telephone (301) 435-6823 or (301) 435-6819, FAX (301) 435-3710, or E-
    mail your request, including your address, to wideroff@nih.gov or 
    Andrew__Freedman@nih.gov.
    
    COMMENTS DUE DATE: Comments regarding this information collection are 
    best assured of having their full effect if received on or before March 
    8, 1999.
    
        Dated: December 29, 1998.
    Reesa Nichols,
    OMB Project Clearance Liaison.
    [FR Doc. 99-108 Filed 1-4-99; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
3/8/1999
Published:
01/05/1999
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
99-108
Dates:
Comments regarding this information collection are best assured of having their full effect if received on or before March 8, 1999.
Pages:
519-520 (2 pages)
PDF File:
99-108.pdf